Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT05132075

1 development in the corpus

NCT05132075

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · PHASE 3 TRIAL

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registry record with no reported results; enrollment is complete but outcome data are not yet posted, making it a planned or ongoing study only.

PreliminaryJDQ443 Non Small Cell Lung Cancer Novartis Pharmaceuticals

Reported

Phase3

Primary endpointProgression free survival (PFS), approximat…

Planned enrollment95

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support